[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fTzq_2nVskgQ9Msq_-H8fCIqJjZJ3sZh3i5EEJztkl6I":8,"$fdwB4ljzS33YlJYE51KgS9M5R92ufVkrEIwfMhAfpScY":55,"$f2IktyCxENIddxSxAJimOkZZZhANkY4etJ2tZN8DcT04":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67471,867154,[],"https://ystcdn.venuertc.com/medical/ystApp/9f9E1y0yGvhcutQOb47OQHSHq70WNvWa.png","王栋","涿州市医院","血液内科","主治医师",312,0,"急性髓系白血病早期治疗用药指南：关键药品安全用药细节全解 💊","","https://ystcdn.venuertc.com/venue/AI/e90525f0-06fb-47b9-8015-74dda30ac39d.jpg","\u003Cdiv id=\"material_title\" class=\"aml-guide-title\">\n  急性髓系白血病早期治疗用药指南：关键药品安全用药细节全解 💊\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section aml-guide-intro\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cp>\n      说起来，化疗和靶向药物是急性髓系白血病（AML）早期治疗的重要用药。不过，具体药品怎么选、如何吃、该注意哪些细节，很多人容易忽略。其实，把握住每一步的用药方法和安全细节，对于提升药效和预防不良反应都有关键作用。本篇就来聊聊AML早期治疗常用药物的7个细致用药要点，让大家掌握实用的技巧，安全合理用药更放心。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 化疗药物的剂型与服用技巧\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>常见药品：\u003C/strong>阿糖胞苷（Cytarabine）、多柔比星（Daunorubicin）、伊达比星（Idarubicin）等，均以注射剂型为主。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>剂型特点：\u003C/strong>阿糖胞苷等需要静脉滴注，不可口服。药品调配和用量必须由医护人员严格掌控。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong>\n        用药当天需要充足进食，保证体力，注射前后多饮水有助于促进代谢及减少肾脏损伤风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊提醒：\u003C/strong>\n        自行拆开或变更剂型极易导致药效变化和严重副作用，绝不可私自处理药品。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"aml-guide-case\">\n      👨‍⚕️ 临床上，阿糖胞苷的剂量须严格计算，尤其是集中疗程期间，剂量误差会带来较大影响。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 服用时间与注射管理细节\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>时间安排：\u003C/strong>化疗药物注射通常在上午进行，便于当天观察身体反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>管理细节：\u003C/strong>用药后至少需在医疗机构观察，防止急性反应。阿糖胞苷连续多天注射时，应严格按照医嘱安排时间，不可提前或延后擅自调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>饮食搭配：\u003C/strong>化疗当天建议清淡饮食，避免高油脂及刺激性食物，有助于减少胃肠道反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>补水建议：\u003C/strong>适度多饮水，有利于药物代谢和减少肾脏损伤。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"aml-guide-case\">\n      👩‍⚕️ 有位患者按照每日同一时间注射阿糖胞苷，观察到身体更易适应，副作用减少。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 靶向药物的服用方法和细节👀\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>代表药品：\u003C/strong>米哚妥林（Midostaurin）为常用靶向药物，口服胶囊剂型。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>服药要求：\u003C/strong>米哚妥林胶囊建议在餐后服用，以减少胃肠不适。不应与酸性饮料混服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>吞服技巧：\u003C/strong>应整粒吞服，不能嚼碎或掰开，每次用温水送服，避免热水或酒精。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong>如漏服一剂，不能补服，应跳过，按原计划服用下一剂。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"aml-guide-case\">\n      💡 一名患者服用米哚妥林时，严格遵循餐后整粒吞服原则，未出现胃肠不适。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用与避免方案🧬\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>常见相互作用：\u003C/strong>米哚妥林与强效CYP3A4抑制剂（如酮康唑等抗真菌药）重叠服用可能显著增加血药浓度。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong>使用期间避免与酮康唑、伊曲康唑、红霉素等药物同时服用。如必须联合，务必咨询医生调整剂量或更换药品。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>食物干扰：\u003C/strong>葡萄柚和葡萄柚汁能影响多种药物（如米哚妥林、维生素K拮抗剂），建议治疗期内不食用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>非处方药提醒：\u003C/strong>避免随意服用感冒药、止痛药等，部分成分可能与化疗药发生相互作用导致毒性增强。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"aml-guide-case\">\n      📝 说明书提示：米哚妥林联合CYP3A4抑制剂时需密切监控药物浓度。\u003Cbr>\n      \u003Cspan class=\"aml-guide-data\">[Stone RM, DeAngelo DJ, Klimek V, et al. Midostaurin in AML therapy. The New England Journal of Medicine, 2017; 377(21): 2032-2043. doi:10.1056/NEJMoa1701818]\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 不良反应表现及紧急处理方式 😷\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>主要不良反应：\u003C/strong>\n        化疗药如阿糖胞苷易产生骨髓抑制（白细胞、血小板下降）、胃肠道反应（恶心、呕吐）、脱发等。米哚妥林等靶向药常见腹泻、皮疹、恶心。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong>\n        发现持续性发热、严重腹泻、出血倾向等症状需及时就医。出现轻度反应（如轻微恶心）、可按医生建议调整饮食，否则不可自行停药或减量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>处理措施：\u003C/strong>\n        化疗期间应密切监控血常规，及时补充止吐、升白、升血小板药物支援。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>数据说明：\u003C/strong>\n        临床研究显示，阿糖胞苷不良反应发生率约85%，米哚妥林为62.3%，但多数为可控的轻中度。\\ \n        \u003Cspan class=\"aml-guide-data\">[Döhner H, Estey E, Amadori S, et al. Diagnosis and management of AML: 2017 ELN recommendations. Blood, 2017; 129(4): 424-447. doi:10.1182/blood-2016-08-733196]\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 适应症与禁忌症的区分使用📑\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>适应症列表：\u003C/strong>\n        阿糖胞苷、多柔比星、伊达比星等用于AML的诱导与巩固治疗；米哚妥林用于特定基因突变型AML的辅助用药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊人群禁忌：\u003C/strong>\n        孕妇、哺乳期妇女原则上禁止使用大部分化疗药及米哚妥林。严重肝肾功能不全者需评估风险后使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过敏史管理：\u003C/strong>\n        有药物过敏史者切忌使用同类药物，首次用药需观察半小时以上，防止急性过敏反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>联合用药注意：\u003C/strong>\n        禁止与某些心脏病药物（如某类抗心律失常药）同时服用，以免增加毒性风险。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 储存条件和药品时效管理🧊\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>存储环境：\u003C/strong>\n        阿糖胞苷、多柔比星等注射制剂应储存于2-8℃的冰箱内，不可冷冻。米哚妥林胶囊应密封室温（15-25℃）保存，远离潮湿。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>开封保存：\u003C/strong>\n        注射药物开封需当天使用，剩余药品不可存放反复使用。胶囊类药品开瓶后40天内用完。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过期处理：\u003C/strong>\n        过期药品切勿服用，应送指定医疗机构或药房处置，避免环境污染和安全风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>药品鉴别：\u003C/strong>\n        出现变色、破损、气味异常的药品，绝不应继续使用。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Ch2 class=\"aml-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 遗漏与过量服用的应对措施⏰\u003C/h2>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>漏服补救：\u003C/strong>\n        靶向药如米哚妥林，漏服应跳过，不能擅自补服或加量，否则易导致药物中毒风险。化疗药错过注射需立即与主治医生确认补救方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量危害：\u003C/strong>\n        过量服用阿糖胞苷、多柔比星可致严重骨髓抑制以及器官损伤，米哚妥林过量则易出现严重消化道症状甚至心律失常。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>紧急处理方法：\u003C/strong>\n        发生过量应马上前往医院处理，常用措施包括洗胃、加速排泄和症状支援，绝不可等待家庭自愈。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section aml-guide-summary\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Ch3 class=\"aml-guide-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结 &amp; 核心提醒✨\u003C/h3>\n    \u003Cp>\n      急性髓系白血病早期治疗常用的化疗药和靶向药，都有严格的管理要求和不容忽视的细节。药品类型和用法各异，剂型、时间、相互作用、不良反应、储存和漏服处理，每一步都要把握到位。\u003Cbr>\n      最重要的是：\u003Cstrong>所有方案都应在医生指导下执行，发现异常反应必须及时就医。\u003C/strong>合理用药，才能最大可能发挥药物效益，降低风险。\n    \u003C/p>\n    \u003Cp class=\"aml-guide-summary-key\">\n      核心建议：\u003Cstrong>严格按剂型和用法执行，不随意增加或减少剂量，注意药物相互作用与存储条件。\u003C/strong>\n    \u003C/p>\n    \u003Cp>\n      若有疑问，不妨咨询专业医师或药师，做到安全用药，护航健康。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"aml-guide-section aml-guide-references\">\n  \u003Cdiv class=\"aml-guide-bg\">\u003C/div>\n  \u003Cdiv class=\"aml-guide-inner\">\n    \u003Ch3 class=\"aml-guide-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">英文参考文献\u003C/h3>\n    \u003Cul>\n      \u003Cli>\n        Stone RM, DeAngelo DJ, Klimek V, et al. (2017). Midostaurin plus chemotherapy for acute myeloid leukemia. \u003Ci>New England Journal of Medicine\u003C/i>, 377(21): 2032-2043. \u003Ca href=\"https://doi.org/10.1056/NEJMoa1701818\" target=\"_blank\">https://doi.org/10.1056/NEJMoa1701818\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Döhner H, Estey E, Amadori S, et al. (2017). Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. \u003Ci>Blood\u003C/i>, 129(4): 424-447. \u003Ca href=\"https://doi.org/10.1182/blood-2016-08-733196\" target=\"_blank\">https://doi.org/10.1182/blood-2016-08-733196\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Tallman MS, Wang ES, Altman JK, et al. (2016). Acute myeloid leukemia: Challenging questions and evolving paradigms. \u003Ci>Leukemia\u003C/i>, 30(8): 1652-1667. \u003Ca href=\"https://doi.org/10.1038/leu.2016.144\" target=\"_blank\">https://doi.org/10.1038/leu.2016.144\u003C/a>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.aml-guide-title {\n  font-size: 32px;\n  color: #3E3A3A;\n  font-weight: bold;\n  padding: 28px 0 16px 0;\n  text-align: center;\n  letter-spacing: 2px;\n  border-bottom: 1px solid #EBEBEB;\n  background: linear-gradient(90deg,#f3e8ee 0%,#e1eafc 100%);\n}\n.aml-guide-section {\n  margin: 40px 0;\n  position: relative;\n  padding: 0;\n}\n.aml-guide-bg {\n  position: absolute;\n  top:0;\n  left:0;\n  right:0;\n  bottom:0;\n  z-index:0;\n  border-radius: 16px;\n  min-height: 150px;\n  background: linear-gradient(135deg, #EAF1FB 0%, #FCEFEF 100%);\n  opacity: 0.48;\n  pointer-events: none;\n}\n.aml-guide-intro .aml-guide-bg {\n  background: linear-gradient(100deg, #DBF1FA 0%, #F7F3FC 100%);\n  opacity: 0.38;\n}\n.aml-guide-inner {\n  position: relative;\n  z-index: 2;\n  padding: 36px 34px 26px 34px;\n  font-size: 18px;\n  line-height: 1.8;\n  background: none;\n  border-radius: 14px;\n}\n.aml-guide-subtitle {\n  font-size: 26px;\n  font-weight: 600;\n  letter-spacing: 1px;\n  margin-top: 0;\n  margin-bottom: 18px;\n  color: #3a4965;\n  background: linear-gradient(96deg,#e6f5eb 0%,#f6edfa 100%);\n  padding: 16px 22px;\n  border-radius: 9px;\n  box-shadow: 0 2px 6px #f4f3ee50;\n}\n.aml-guide-inner ul {\n  margin-left: 16px;\n  padding-left: 16px;\n}\n.aml-guide-inner li {\n  margin-bottom: 10px;\n  font-size: 17px;\n}\n.aml-guide-case {\n  border-left: 4px solid #bfb2e9;\n  background: #f6f2fd;\n  font-size: 17px;\n  margin-top: 18px;\n  padding: 14px 18px;\n  color: #655488;\n  border-radius: 8px;\n}\n.aml-guide-data {\n  color: #444;\n  background: #eddeeb;\n  padding: 3px 9px;\n  border-radius: 10px;\n  margin-left: 18px;\n  font-size: 17px;\n}\n.aml-guide-summary {\n  box-shadow: 0 4px 24px #f7ecee25;\n  border-radius: 14px;\n}\n.aml-guide-summary-title {\n  font-size: 22px;\n  color: #56467f;\n  margin-bottom: 12px;\n  font-weight: bold;\n}\n.aml-guide-summary-key {\n  font-size: 19px;\n  color: #B260C5;\n  font-weight: 700;\n  margin: 18px 0;\n  background: #f5e4ff;\n  padding: 10px 22px;\n  border-radius: 8px;\n}\n.aml-guide-references ul {\n  margin-left: 20px;\n  padding-left: 15px;\n}\n.aml-guide-references li {\n  font-size: 15px;\n  line-height: 1.7;\n  margin-bottom: 7px;\n  color: #565662;\n}\n.aml-guide-references a {\n  color: #4578bf;\n  text-decoration: underline;\n  word-break: break-all;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"aml-guide-title\">\n  急性髓系白血病早期治疗用药指南：关键药品安全用药细节全解 💊\n\u003C/div>\n\n\u003Cdiv cla",297,"2025-10-09 09:24:35","急性髓系白血病, 化疗药物, 靶向药物, 用药安全, 不良反应","了解急性髓系白血病（AML）早期治疗的重要用药技巧，掌握化疗和靶向药物的服用细节，确保安全合理用药，提升疗效并降低不良反应风险。","2025-10-14 22:01:33",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]